Diagnostic value of neuropsychological tests for assessing changes in cognitive functions during normal aging
https://doi.org/10.37586/2949-4745-1-2025-22-34
Abstract
Cognitive tests are standardized tasks that allow quantifying various aspects of human higher nervous activity. They are widely used to diagnose cognitive impairments in neurological and mental illnesses, as well as to monitor agerelated cognitive changes. Each test aims at specific cognitive domains — memory, attention, executive functions, information processing speed, etc. Together, they provide a holistic view of the cognitive profile of the subject. This review article examines the most commonly used cognitive tests, from ACE-III type screening batteries to specialized tests for memory, attention and motor-perceptual skills. The principles of their implementation and their diagnostic value in population studies and clinical practice are discussed for assessing cognitive functions during normal aging.
About the Authors
A. I. Dudinova
Pirogov Russian National Research Medical University, Russian Gerontology Research and Clinical Centre
Russian Federation
Russian Federation
Dudinova Anna Igorevna.
Moscow.
M. S. Legenko
Pirogov Russian National Research Medical University, Russian Gerontology Research and Clinical Centre
Russian Federation
Russian Federation
Moscow.
I. D. Strazhesko
Pirogov Russian National Research Medical University, Russian Gerontology Research and Clinical Centre
Russian Federation
Russian Federation
Moscow.
References
1. Navarro D., Gasparyan A., Martí Martínez S., et al. Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach. Int J Mol Sci. 2023; 24 (8): 7653. Published 2023 Apr 21. DOI: 10.3390/ijms24087653.
2. Harada C. N., Natelson Love M. C., Triebel K. L. Normal cognitive aging. Clin Geriatr Med. 2013; 29 (4): 737–752. DOI: 10.1016/j.cger.2013.07.002.
3. Fällman K., Lundgren L., Wressle E., Marcusson J., Classon E. Normative data for the oldest old: Trail Making Test A, Symbol Digit Modalities Test, Victoria Stroop Test and Parallel Serial Mental Operations. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2020; 27 (4): 567–580. DOI: 10.1080/13825585.2019.1648747.
4. Scheffels J. F., Ballasch I., Scheichel N., Voracek M., Kalbe E., Kessler J. The Influence of Age, Gender and Education on Neuropsychological Test Scores: Updated Clinical Norms for Five Widely Used Cognitive Assessments. J Clin Med. 2023; 12 (16): 5170. DOI: 10.3390/jcm12165170.
5. Potts C., Richardson J., Bond R. B., et al. Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems. Eur J Ageing. 2021; 19 (3): 495–507. Published 2021 Sep 22. DOI: 10.1007/s10433-021-00652-4.
6. Varako N. A., Arkhipova D. V., Kovyazina M. S., Yusupova D. G., Zaytsev A. B., Zimin A. A., Solomina A. V., Bundhun P., Ramchandani N. M., Suponeva N. A., Piradov M. A. The Addenbrooke’s Cognitive Examination III (ACE-III): linguistic and cultural adaptation into Russian. Annals of clinical and experimental neurology. 2022; 16 (1): 53–58. (In Russ). DOI: 10.54101/ACEN.2022.1.7.
7. Matias-Guiu J. A., Cortés-Martínez A., Valles-Salgado M., et al. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests. Int Psychogeriatr. 2017; 29 (1): 105–113. DOI: 10.1017/S1041610216001496.
8. Jubb M. T., Evans J. J. An Investigation of the Utility of the Addenbrooke's Cognitive Examination III in the Early Detection of Dementia in Memory Clinic Patients Aged over 75 Years. Dement Geriatr Cogn Disord. 2015; 40 (3–4): 222–232. DOI: 10.1159/000433522.
9. Hsieh S., Schubert S., Hoon C., Mioshi E., Hodges J. R. Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2013; 36 (3–4): 242–250. DOI: 10.1159/000351671.
10. Jaeger J. Digit Symbol Substitution Test: The Case for Sensitivity Over Specificity in Neuropsychological Testing. J Clin Psychopharmacol. 2018; 38 (5): 513–519. DOI: 10.1097/JCP.0000000000000941.
11. Mizuno A., Karim H. T., Ly M. J., et al. Low thalamic activity during a digit-symbol substitution task is associated with symptoms of subjective cognitive decline. Front Psychiatry. 2023; 14: 1242822. DOI: 10.3389/fpsyt.2023.1242822.
12. Brody D. J., Kramarow E. A., Taylor C. A., McGuire L. C. Cognitive Performance in Adults Aged 60 and Over: National Health and Nutrition Examination Survey, 2011–2014. Natl Health Stat Report. 2019; (126): 1–23.
13. Du M., Andersen S. L., Cosentino S., Boudreau R. M., Perls T. T., Sebastiani P. Digitally generated Trail Making Test data: Analysis using hidden Markov modeling. Alzheimers Dement (Amst). 2022; 14 (1): e12292. DOI: 10.1002/dad2.12292.
14. Ashendorf L., Jefferson A. L., O'Connor M. K., Chaisson C., Green R. C., Stern R. A. Trail Making Test errors in normal aging, mild cognitive impairment, and dementia. Arch Clin Neuropsychol. 2008; 23 (2): 129–137. DOI: 10.1016/j.acn.2007.11.005.
15. Linari I., Juantorena G. E., Ibáñez A., Petroni A., Kamienkowski J. E. Unveiling Trail Making Test: visual and manual trajectories indexing multiple executive processes. Sci Rep. 2022; 12 (1): 14265. DOI: 10.1038/s41598-022-16431-9.
16. Hamdan A. C., Vieira M. D. Stroop Test for Parkinson's Disease with Deep Brain Stimulation: A Systematic Review. Innov Clin Neurosci. 2022; 19 (10–12): 29–34.
17. Idowu M. I., Szameitat A. J., Parton A. The assessment of executive function abilities in healthy and neurodegenerative aging-A selective literature review. Front Aging Neurosci. 2024; 16: 1334309. DOI: 10.3389/fnagi.2024.1334309.
18. Parris B. A., Hasshim N., Wadsley M., Augustinova M., Ferrand L. The loci of Stroop effects: a critical review of methods and evidence for levels of processing contributing to color-word Stroop effects and the implications for the loci of attentional selection. Psychol Res. 2022; 86 (4): 1029–1053. DOI: 10.1007/s00426-021-01554-x.
19. Schultz D. H., Gansemer A., Allgood K., et al. Second language learning in older adults modulates Stroop task performance and brain activation. Front Aging Neurosci. 2024; 16: 1398015. DOI: 10.3389/fnagi.2024.1398015.
20. Bahri M., Farrahi H., Mahdavinataj H., Batouli S. A. H. Eight brain structures mediate the age-related alterations of the working memory: forward and backward digit span tasks. Front Psychol. 2024; 15: 1377342. DOI: 10.3389/fpsyg.2024.1377342.
21. Monaco M., Costa A., Caltagirone C., Carlesimo G. A. Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population. Neurol Sci. 2013; 34 (5): 749–754. DOI: 10.1007/s10072-012-1130-x.
22. Egeland J., Lund O., Raudeberg R. Measuring working memory span with WAIS-IV: Digit sequence is the superior span test. Appl Neuropsychol Adult. Published online January 20, 2025. DOI: 10.1080/23279095.2024.2330998.
23. Ruchinskas R. (2019). Wechsler adult intelligence scale-4th edition digit span performance in subjective cognitive complaints, amnestic mild cognitive impairment, and probable dementia of the Alzheimer type. The Clinical Neuropsychologist, 33 (8), 1436–1444. DOI: 10.1080/13854046.2019.1585574.
24. Yu B., Li M., Yu Z., et al. Red blood cell distribution width to albumin ratio (RAR) is associated with low cognitive performance in American older adults: NHANES 2011–2014. BMC Geriatr. 2025; 25 (1): 157. DOI: 10.1186/s12877-025-05800-4.
25. Hankee L. D., Preis S. R., Piers R. J., et al. Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study. Exp Aging Res. 2016; 42 (4): 315–328. DOI: 10.1080/0361073X.2016.1191838.
26. Shankle W. R., Romney A. K., Hara J., et al. Methods to improve the detection of mild cognitive impairment. Proc Natl Acad Sci U S A. 2005; 102 (13): 4919–4924. DOI: 10.1073/pnas.0501157102.
27. Ren H., Feng Q., Chen L., et al. Ten-words recall test: an effective tool to differentiate mild cognitive impairment from subjective cognitive decline. Front Psychiatry. 2024; 15: 1429934. DOI: 10.3389/fpsyt.2024.1429934.
28. de Winter J. C. F., Dodou D., Eisma Y. B. Responses to Raven matrices: Governed by visual complexity and centrality. Perception. 2023; 52 (9): 645–661. DOI: 10.1177/03010066231178149.
29. Raven’s Progressive Matrices: Methodological Recommendations / compiled and generally edited by O. E. Mukhordova, T. V. Shreiber. — Izhevsk: Publishing House “Udmurt University”, 2011. — 70 p.]
30. Yu Z., Wu X., Jiang R., et al. Feasibility and Engagement of Multi-domain Cognitive Training in Community-Dwelling Healthy Elderly in Shanghai. Front Psychiatry. 2022; 12: 781050. DOI: 10.3389/fpsyt.2021.781050.
31. Kramer A. W., Huizenga H. M. Raven's Standard Progressive Matrices for Adolescents: A Case for a Shortened Version. J Intell. 2023; 11 (4): 72. DOI: 10.3390/jintelligence11040072.
32. Murphy P., Foley J., Mole J., Van Harskamp N., Cipolotti L. Lifespan normative data (18–89 years) for Raven's Advanced Progressive Matrices Set I. J Neuropsychol. 2023; 17 (2): 417–429. DOI: 10.1111/jnp.12308.
33. Zhang X., Lv L., Min G., Wang Q., Zhao Y., Li Y. Overview of the Complex Figure Test and Its Clinical Application in Neuropsychiatric Disorders, Including Copying and Recall. Front Neurol. 2021; 12: 680474. DOI: 10.3389/fneur.2021.680474.
34. Solovyova A. P., Goryachev D. V., Arkhipov V. V. Criteria for assessment of cognitive impairment in clinical trials. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya. Тhе Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2018; 8 (4): 218–230. (In Russ). DOI: 10.30895/1991-2919-2018-8-4-218-230].
35. Clinical guidelines: Cognitive disorders in elderly and senile individuals. Developer of the clinical guidelines: All-Russian public organization “Russian Association of Gerontologists and Geriatricians”, Public organization “Russian Society of Psychiatrists”, All-Russian Society of Neurologists. Year of approval 2024. (In Russ).
36. Cipriani G. E., Molfese S., Giovannelli F., et al. Executive control from healthy ageing to cognitive impairment: A systematic review of stroop and simon effects using psychophysiological and imaging techniques. Neurosci Biobehav Rev. 2025; 172: 106121. DOI: 10.1016/j.neubiorev.2025.106121.
Review
For citations:
Dudinova A.I., Legenko M.S., Strazhesko I.D. Diagnostic value of neuropsychological tests for assessing changes in cognitive functions during normal aging. Problems of Geroscience. 2025;(1):22-34. (In Russ.) https://doi.org/10.37586/2949-4745-1-2025-22-34
Views:
351
JATS XML
Email this article .jpg)
